(1) A retrospective study was done in 86 patients on dialysis in order to evaluate the doses of aluminum hydroxide (OH3 Al) received to achieve a better serum phosphate control.
(2) These results suggest that aluminum is able to gain access to the central nervous system under normal physiological conditions.
(3) Marked declines in stainable bone-surface aluminum were associated with increases in bone formation rate and osteoblastic osteoid following deferoxamine.
(4) This is suggested by the fact that patients with overt hyperparathyroidism are protected from developing aluminum-related bone disease even when they are given large parenteral loads of aluminum.
(5) The 8 men and 3 women were clinically stable, were known to be compliant, and had no clinical evidence of aluminum overload; they were not receiving vitamin D supplements; and they had been on dialysis for an average of 65.6 months (range: 13-188 months).
(6) The neurotransmitter alterations which accompany aluminum neurofibrillary degeneration were examined in order to assess how closely they mimic those of Alzheimer's disease.
(7) Children with renal failure, on aluminum supplementation, should be carefully monitored for toxicity.
(8) From the existing data, 2 g deferoxamine administration intraperitoneally three times per week in the overnight exchange appears to provide the maximum aluminum removal for minimum deferoxamine dosage.
(9) After exposure to 400 microM aluminum lactate and removal of unbound aluminum, human cytoskeletal proteins were degraded two- to threefold more slowly by calpain.
(10) BDF1 mice were immunized with a protein antigen, such as ovalbumin (OA) or keyhole limpet hemocyanin (KLH), absorbed to aluminum hydroxide gel, and their spleen cells were stimulated by homologous antigen for the formation of glycosylation-enhancing factor (GEF).
(11) Chronic dietary deficiency of calcium (Ca) and magnesium (Mg) with excessive intake of aluminum (Al) and manganese (Mn) has been implicated in the pathogenesis of high incidence amyotrophic lateral sclerosis (ALS) in the Western Pacific.
(12) The growth plates did not increase in width despite the presence of osteomalacia and histologic evidence of extensive deposition of aluminum in bone.
(13) The monovalent serovar C aluminum-hydroxide-gel vaccine also gave significant protection (94%) against a serovar C challenge.
(14) Two different prototypes of columella materials made from aluminum oxide ceramics were newly designed by the author for ossicular reconstruction.
(15) The trienone XIII was subsequently epoxidised with alkaline hydrogen peroxide and m-chloroperbenzoic acid to give diepoxide XV which was reduced with aluminum amalgam to the final product V.
(16) To test the technique, a feasibility study was performed with known thicknesses of aluminum (simulating bone), lucite (simulating tissue), and polyethylene (simulating fat).
(17) The dissolution t50 and various pharmacokinetic parameters showed directly compressible starch and carboxymethylstarch to be the most effective disintegrants in the concentrations employed while magnesium aluminum silicate and microcrystalline cellulose were about equal but less effective than the previous disintegrants.
(18) when an aluminum plate is imaged, forms the basic Q.C.
(19) The effect of aluminum phosphate on the bioavailability of ranitidine has been investigated in 10 young, healthy volunteers.
(20) Furthermore, a Gh.PLC complex can be induced by incubation with aluminum fluoride in a detergent solution and partially purified without the dissociation of related proteins.
Halotrichite
Definition:
(n.) An iron alum occurring in silky fibrous aggregates of a yellowish white color.